Related content

Pharmacokinetic evaluation of agomelatine for the treatment of generalised anxiety disorder

By Buoli Massimiliano   Mauri Massimo Carlo   Altamura Alfredo Carlo  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 10, Iss. 6, 2014-06 ,pp. : 885-892

Informa Healthcare

Access to resources Recommend Favorite

The efficacy of agomelatine appears to extend to generalised anxiety disorder (GAD)

By  

Inpharma, Vol. 1, Iss. 1660, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Pediatric Generalized Anxiety Disorder: Epidemiology, Diagnosis, and Management

By >   Kolos Amie C.   Walkup John T.  

Pediatric Drugs, Vol. 11, Iss. 3, 2009-05 ,pp. : 171-183

Adis International

Access to resources Recommend Favorite

New approaches to the pharmacological management of generalized anxiety disorder

By Buoli Massimiliano   Caldiroli Alice   Caletti Elisabetta   Paoli Riccardo Augusto   Altamura Alfredo Carlo  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 2, 2013-02 ,pp. : 175-184

Informa Healthcare

Access to resources Recommend Favorite

Current Considerations in the Treatment of Generalized Anxiety Disorder

By Katzman Martin A.  

CNS Drugs, Vol. 23, Iss. 2, 2009-01 ,pp. : 103-120

Adis International

Access to resources Recommend Favorite